|
Canada-0-Insurance Azienda Directories
|
Azienda News:
- ASCVD Risk Estimator
Forecast the potential impact of different interventions on patient risk Reassess ASCVD risk at follow-up visits Follow up risk incorporates change in risk factor levels over time and requires both initial and follow up values Use the information above to help with clinician-patient discussions on risk and risk-lowering interventions
- ASCVD Risk Estimator - American College of Cardiology
Y es N o *Intended for use if there is not ASCVD and the LDL-cholesterol is <190 mg dL **Optimal risk factors include: Total cholesterol of 170 mg dL, HDL-cholesterol of 50 mg dL, Systolic BP of 110 mm Hg, Not taking medications for hypertension, Not a diabetic, Not a smoker
- ASCVD Risk Estimator - American College of Cardiology
ASCVD Risk Estimator Intended for patients with LDL-C < 190 mg dL (4 92 mmol L), without ASCVD, not on LDL-C lowering therapy Reset All
- American College of Cardiology Calculator Home - American College of . . .
Access a variety of cardiology calculators and tools provided by the American College of Cardiology
- About ACC Calculator Home - American College of Cardiology App Home
In order to support the implementation of these guidelines the ACC and AHA have jointly published a new mobile application (app) The ASCVD Risk Estimator application helps health care providers and patients estimate 10-year and lifetime risks for atherosclerotic cardiovascular disease (ASCVD) using the Pooled Cohort Equations and lifetime risk
- Multilingual ASCVD Risk Estimator Web App
The Multilingual ASCVD Risk Estimator is a simplified web-based version of the ASCVD Risk Estimator Plus app that provides clinicians with an efficient way to calculate a patient’s estimated 10-year ASCVD risk, optimal risk and lifetime risk
- Lipid Manager - American College of Cardiology
This app does not yet include content from the 2026 ACC AHA Multisociety Guideline on the Management of Dyslipidemia This app will be updated to reflect this guidance in mid-May, 2026
- Statin Intolerance - American College of Cardiology
This tool should be used by clinicians to assess, treat, and manage patients with possible statin intolerance Although muscle symptoms may occur, true statin intolerance is uncommon Given the benefits of statins in ASCVD risk reduction, clinicians should partner with the patient to gain a thorough symptom history and determine if he or she is truly statin intolerant Walk through the steps
- Statin Intolerance - tools. acc. org
This tool should be used by clinicians to assess, treat, and manage patients with possible statin intolerance Although muscle symptoms may occur, true statin intolerance is uncommon Given the benefits of statins in ASCVD risk reduction, clinicians should partner with the patient to gain a thorough symptom history and determine if he or she is truly statin intolerant Walk through the steps
- Hypertriglyceridemia - American College of Cardiology
This app does not yet include content from the 2026 ACC AHA Multisociety Guideline on the Management of Dyslipidemia This app will be updated to reflect this guidance in mid-May, 2026
|
|